Bone Health and Collagen: The Structural Foundation

When people think about bone health, they think about calcium, vitamin D  and weight-bearing exercise. These are all valid. But there is one structural piece of the puzzle that rarely gets discussed, and it sits at the very core of what bone actually is.

Collagen is the primary structural protein of bone. It forms the organic matrix that gives bone its framework, flexibility and the scaffold onto which calcium crystals are deposited. From around the age of 25, collagen synthesis begins to decline at roughly 1% per year, and bone is one of the first tissues where that structural decline has measurable, long term consequences.

This blog explores why the collagen matrix is as important as calcium to bone health, how collagen loss contributes to bone fragility and how targeted collagen peptide supplementation, alongside evidence-based nutrition habits can support bone density from the inside out.

Why bone is not just calcium

Bone is not a static mineral deposit. It is a living, dynamic tissue made up of two primary components working together, described as an organic matrix and a mineral phase. The organic matrix, accounting for approximately 25% of bone by weight, is composed almost entirely of Type I collagen, which makes up around 94% of it (International Osteoporosis Foundation, 2019). The mineral phase, hydroxyapatite, a crystalline complex of calcium and phosphate accounts for roughly 70% of bone weight and is deposited within and around the collagen fibril scaffold (International Osteoporosis Foundation, 2019).

Collagen provides the structural template onto which calcium phosphate crystals are anchored. Without a healthy collagen matrix, calcium has no scaffold to mineralise, much like concrete without steel reinforcement. The result is bone that is not only thinner, but also more brittle and fracture prone, regardless of calcium intake (IOF, 2019; PMC, Matrix Vesicle Mineralisation, 2022).

When collagen production declines with age, the organic matrix thins and deteriorates. Osteoblasts, which are the bone forming cells responsible for laying down new collagen become less active. Osteoclasts, the cells responsible for breaking down old bone continue their work at a relatively higher rate, tipping the balance toward net bone loss. The clinical result is osteopenia (low bone density) and  in more advanced cases, osteoporosis, a condition characterised by fragile bones and elevated fracture risk.

How collagen decline affects bone

Bone is continuously being remodelled throughout life. Old bone is broken down by osteoclasts and new bone is laid down by osteoblasts in a carefully regulated cycle. In youth, formation outpaces resorption and bone mass increases. Peak bone mass is typically reached in the late twenties. After that, the balance shifts and from around the age of 35, most adults begin to lose bone mass gradually (IOF, 2019).

The rate of that loss is heavily influenced by collagen. Osteoblasts do not simply deposit calcium, they first produce osteoid, a collagen rich organic matrix that provides the structural foundation for mineralisation (IOF, 2019). When collagen synthesis slows, osteoid production declines and the mineral phase has less template to work with. The result is a gradual reduction in bone quality, not just bone density.

For women, this process accelerates sharply at menopause. The drop in oestrogen that accompanies menopause significantly increases osteoclast activity and reduces the efficiency of bone formation, resulting in rapid bone loss, particularly in the first five years post menopause. Women can lose up to 20% of their bone density in the decade following menopause, making this period the most critical window for targeted bone health support (IOF, 2019).

The key amino acids: glycine, proline, and hydroxyproline

Understanding why collagen supports bone health requires a look at the amino acids that make it up. Collagen is uniquely rich in three amino acids that are directly relevant to bone matrix formation:

Glycine is the most abundant amino acid in collagen, making up approximately one third of its composition. In bone, glycine provides the repeating structural unit of the collagen triple helix and is essential for osteoblast function, the cells that produce new bone matrix. Glycine is a conditionally essential amino acid, meaning the body's demand for it under conditions of high turnover, stress or age-related decline can exceed what typical dietary intake supplies (Sun et al., 2025).

Proline is essential for the formation and stability of the collagen triple helix and is directly involved in the synthesis of osteoid, which is the collagen rich organic layer that forms the foundation of new bone. It also plays a role in supporting the mechanical flexibility of the bone matrix, which contributes to fracture resistance (IOF, 2019).

Hydroxyproline is a modified form of proline found almost exclusively in collagen. It stabilises the triple helix structure and is a recognised marker of collagen turnover in bone. Hydroxyproline containing peptides absorbed from collagen supplementation have been shown to reach bone tissue and directly stimulate osteoblast activity, making collagen supplementation one of the few practical ways to significantly increase its availability in bone (GELITA, 2025; Sun et al., 2025).

What the clinical research shows

FORTIBONE® and bone mineral density

FORTIBONE® is GELITA®'s patented bioactive collagen peptide developed specifically for bone health, and the only collagen peptide with dedicated clinical evidence for improving bone mineral density in humans. It works by stimulating osteoblasts to increase collagen and osteoid production, while simultaneously reducing osteoclast activity, shifting the bone remodelling balance toward formation over breakdown (GELITA, 2025).

The foundational randomised, double-blind, placebo-controlled trial  enrolled 131 postmenopausal women with age-related reduction in BMD (König et al., 2018). After 12 months of 5 g FORTIBONE® daily, spinal BMD T-score increased by +0.1 versus −0.03 in placebo  and femoral neck T-score increased by +0.09 versus −0.01. The bone formation marker P1NP rose significantly in the FORTIBONE® group, while the bone resorption marker CTX-1 rose in the placebo group, a pattern of accelerating breakdown not seen in those supplementing.

A four year follow up confirmed these gains were durable, with BMD continuing to improve or maintain in both the spine and femoral neck with no adverse effects reported (Zdzieblik et al., 2021). A separate randomised study  found that adding 5 g of FORTIBONE® to an established calcium and vitamin D regimen produced a significant reduction in bone turnover markers, an effect not seen with calcium and vitamin D alone (Argyrou et al., 2020).

The broader evidence base supports these findings. A 2025 meta-analysis in Frontiers in Nutrition confirmed that collagen peptide supplementation significantly increased BMD in both the femoral neck and spine across multiple randomised controlled trials, with the strongest effects seen when combined with calcium and vitamin D (Sun et al., 2025).

How Complete Body Collagen supports bone health

Live More You Complete Body Collagen delivers a daily 17.5 g serve of four clinically studied GELITA® bioactive collagen peptides: FORTIGEL® (5 g), FORTIBONE® (5 g), TENDOFORTE® (5 g) and VERISOL® (2.5 g). FORTIBONE® is the primary peptide for bone health, delivered at the exact 5 g dose used in every published clinical trial.

At 5 g of FORTIBONE® per serve, Complete Body Collagen meets the exact clinical dose shown to improve BMD and shift bone turnover markers in postmenopausal women, making it one of the few products on the Australian market to deliver this peptide at a clinically meaningful level.

It is also worth noting the role of VERISOL® in this context. While VERISOL® is primarily studied for skin, hair and nail outcomes, its 2.5 g dose contributes Type I and Type III collagen peptides alongside the same glycine, proline, and hydroxyproline amino acids that support the bone matrix. For postmenopausal women in particular who face accelerated loss of both bone density and skin collagen, following the drop in oestrogen, the inclusion of VERISOL® means Complete Body Collagen addresses two of the most visible consequences of menopause simultaneously, structural bone support through FORTIBONE®, and dermal collagen support through VERISOL®. A double-blind, placebo-controlled trial demonstrated a 20% reduction in eye wrinkle volume and significant improvements in skin elasticity after eight weeks of 2.5 g VERISOL® daily — the exact dose delivered in each serve. For a population already prioritising bone health, this added benefit comes at no additional dose (Proksch et al., 2024).

Clinical dosing summary for Bone Health

A complete approach to Bone Health

Collagen addresses the structural, organic layer of bone health, but works best as part of a broader strategy. Calcium is the primary mineral component of bone. Australian dietary guidelines recommend 1,300 mg per day for adults over 50, from sources such as dairy, tofu and leafy greens, with supplementation where dietary intake falls short. Vitamin D is essential for calcium absorption and osteoblast function, with deficiency common in Australia particularly among those with limited sun exposure (NHMRC, 2023). Weight bearing exercise, including resistance training, walking and jogging, stimulates osteoblast activity and remains one of the most effective non-pharmacological strategies for maintaining bone density. Finally, minimising known bone disruptors such as smoking, excess alcohol, prolonged corticosteroid use and inadequate protein intake protects the structural gains that collagen and nutritional support provide.

Who may benefit most

While bone collagen support is relevant for most adults from their mid thirties onward, the following groups have the most to gain from targeted collagen supplementation for bone health:

·      Menopausal women as oestrogen decline accelerates bone loss and reduces osteoblast efficiency; FORTIBONE® has its strongest clinical evidence base in this population, while VERISOL® simultaneously addresses the accelerated skin collagen loss that occurs in the same period

·      Adults with osteopenia those with a DXA T-score between −1 and −2.5 are at elevated fracture risk.

·      Adults over 50 due to natural age related bone loss acceleration through the sixth decade and beyond, making preventive collagen support a rational long-term strategy

·      Those with low dietary protein intake as adequate protein, including collagen-specific amino acids, is essential for osteoid production. Those with low protein diets may have compromised bone matrix synthesis

·      Active individuals with high training loads as it causes repeated mechanical stress on bone, and increases the demand for collagen matrix repair.

·      Those with risk factors for osteoporosis including family history, low body weight, smoking and steroid use all increase risk

Safety and how to take it

Hydrolysed collagen peptides are well tolerated at doses up to 15–20 g per day in clinical trials and are considered appropriate for long-term daily use.

Live More You Complete Body Collagen is derived from bovine sources and is not suitable for those following vegetarian or vegan diets, or those with sensitivity to beef-derived ingredients. Those who are pregnant, breastfeeding, or taking prescribed medications, including medications for osteoporosis or bone health, and should consult a healthcare practitioner before commencing use.

Practical guidance:

·      Mix one level scoop (17.5 g) into water, juice, or a smoothie daily

·      Consistency over months is more important than timing. Bone density effects accumulate gradually with sustained supplementation

·      Ensure adequate calcium and vitamin D intake alongside FORTIBONE® to support the mineralisation of the collagen matrix

·      Allow a minimum of 12 months before assessing BMD outcomes, consistent with the trial durations used in clinical research

·      Complete Body Collagen is a nutritional supplement and is not a replacement for medical management of diagnosed osteoporosis

The bottom line

Most bone health conversations focus on calcium and vitamin D, the mineral side of the equation. Fewer address the collagen matrix that gives bone its structure, flexibility and the scaffold that calcium depends on to be useful in the first place.

Collagen is not a replacement for calcium, vitamin D  or weight-bearing exercise. It is the organic foundation that makes those strategies more effective by ensuring the bone matrix itself is sound. As collagen production declines with age, ensuring that decline does not compromise bone matrix quality is a practical, evidence-informed step, particularly for women approaching or following menopause, when the risk of significant bone loss is at its highest.

Live More You Complete Body Collagen delivers four clinically studied peptides at their full clinical doses in a single daily serve, making it a practical choice for those who want whole-body connective tissue support, bone matrix included.

For personalised guidance on bone health and collagen supplementation in the context of your specific needs, consult a qualified healthcare practitioner.

References

Argyrou, C., Karlafti, E., Lampropoulou-Adamidou, K., Makris, K., Trovas, G., Dontas, I. A., Tournis, S., & Triantafyllopoulos, I. K. (2020). Effect of calcium and vitamin D supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia. Journal of Musculoskeletal and Neuronal Interactions, 20(1), 12–17.

GELITA (2025). Proven benefits for bone health metabolism. Retrieved from https://www.gelita.com/en/knowledge/blog/proven-benefits-bone-health-metabolism

International Osteoporosis Foundation (2019). Bone biology. Retrieved from https://www.osteoporosis.foundation/health-professionals/about-osteoporosis/bone-biology

Proksch, E., Schunck, M., Zague, V., Segger, D., Degwert, J., & Oesser, S. (2014). Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacology and Physiology, 27(3), 113–119.

König, D., Oesser, S., Scharla, S., Zdzieblik, D., & Gollhofer, A. (2018). Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women — a randomized controlled study. Nutrients, 10(1), 97. https://doi.org/10.3390/nu10010097

Lampropoulou-Adamidou, K., Karlafti, E., Argyrou, C., Makris, K., Trovas, G., Dontas, I. A., Tournis, S., & Triantafyllopoulos, I. K. (2022). Effect of calcium and vitamin D supplementation with and without collagen peptides on volumetric and areal bone mineral density, bone geometry and bone turnover in postmenopausal women with osteopenia. Journal of Clinical Densitometry, 25(3), 357–372. https://doi.org/10.1016/j.jocd.2021.11.011

PMC (2022). Matrix vesicle-mediated mineralisation and osteocytic regulation of bone mineralisation. https://pmc.ncbi.nlm.nih.gov/articles/PMC9456179

Sun, C., Yang, A., Teng, F., & Xia, Y. (2025). Efficacy of collagen peptide supplementation on bone and muscle health: a meta-analysis. Frontiers in Nutrition, 12, 1646090. https://doi.org/10.3389/fnut.2025.1646090

Zdzieblik, D., Oesser, S., & König, D. (2021). Specific bioactive collagen peptides in osteopenia and osteoporosis: long-term observation in postmenopausal women. Journal of Bone Metabolism, 28(3), 207–213. https://doi.org/10.11005/jbm.2021.28.3.207

This blog is for educational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, or prevent any health condition. Always consult a qualified healthcare practitioner before commencing any new supplement, particularly if you have an existing medical condition, diagnosed bone condition, or are taking prescribed medication